|
Volumn 47, Issue 1218, 2005, Pages 78-80
|
Azithromycin extended-release (Zmax) for sinusitis and pneumonia
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AZITHROMYCIN;
CEFPODOXIME PROXETIL;
CEFUROXIME AXETIL;
CLARITHROMYCIN;
DOXYCYCLINE;
ERY TAB;
ERYTHROMYCIN;
GATIFLOXACIN;
GEMIFLOXACIN;
LEVOFLOXACIN;
MOXIFLOXACIN;
TELITHROMYCIN;
TRI PAK;
WARFARIN;
Z PAK;
ZMAX;
ABDOMINAL PAIN;
ANGIONEUROTIC EDEMA;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
COMMUNITY ACQUIRED PNEUMONIA;
CONTROLLED RELEASE FORMULATION;
COST BENEFIT ANALYSIS;
DIARRHEA;
DRUG DOSE REGIMEN;
DRUG ELIMINATION;
DRUG MECHANISM;
DRUG METABOLISM;
HEARING LOSS;
HUMAN;
JAUNDICE;
NAUSEA;
PHOTOSENSITIVITY;
SHORT SURVEY;
SINUSITIS;
VOMITING;
ADULT;
ARTICLE;
BACTERIAL INFECTION;
COMMUNICABLE DISEASE;
DELAYED RELEASE FORMULATION;
DRUG INTERACTION;
PHYSIOLOGY;
PNEUMONIA;
ADULT;
AZITHROMYCIN;
COMMUNITY-ACQUIRED INFECTIONS;
DELAYED-ACTION PREPARATIONS;
DRUG INTERACTIONS;
HAEMOPHILUS INFECTIONS;
HUMANS;
PNEUMONIA;
SINUSITIS;
|
EID: 26944472860
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (1)
|
References (6)
|